跳轉至內容
Merck
全部照片(2)

文件

P3134

Sigma-Aldrich

磷酸二酯酶I 来源于东部菱背响尾蛇 毒液

Type VI, crude dried venom

同義詞:

5′-核酸外切酶, 寡核苷酸5′-核苷酸水解酶

登入查看組織和合約定價


About This Item

CAS號碼:
酶委員會編號:
EC號碼:
MDL號碼:
分類程式碼代碼:
12352204
NACRES:
NA.54

種類

Type VI

品質等級

形狀

crude dried venom

儲存溫度

−20°C

尋找類似的產品? 前往 產品比較指南

一般說明

Research area: Cell signaling. PhosphodiesteraseI (PDEI) exists in three isoforms PDE1A, PDE1B, and PDE1C(2) are localized to the central nervous system, cardiovascular, and other organs.

應用

响尾蛇毒液中的磷酸二酯酶 I 用于
  • :裂解 3′-5′ 端;RNA 寡聚体线性链中的核苷酸间键
  • 作为磷酸二酯酶法中前体药物水解的模型
  • 作为核苷酸剪切缓冲液中的组分

生化/生理作用

磷酸二酯酶 I 破坏磷酸二酯键并催化各种核苷酸多磷酸盐的水解。通过磷脂酰肌醇特异性磷脂酶 C 从真核质膜释放磷酸二酯酶 I。

象形圖

Health hazard

訊號詞

Danger

危險聲明

防範說明

危險分類

Resp. Sens. 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Chemical toxicity testing in vitro using cytochrome P450--expressing cell lines, such as human CYP1B1
Landsiedel R, et al.
Nature Protocols, 6(5), 677-677 (2011)
Formation of RNA oligonucleotides over the mineral surface preliminary irradiated with UV light
Otroshchenko VA and Vasilyeva NV
Reaction Kinetics and Catalysis Letters, 97(1), 151-156 (2009)
Anatoly I Dragan et al.
Nucleic acids research, 32(17), 5192-5197 (2004-10-02)
The interaction of proteins with DNA results, in some cases, in DNA bending, and this might have functional importance. However, when the protein-induced bending of DNA is small, its measurement presents a problem. It is shown that the fluorescence resonance
Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study
Roux L, et al.
European Journal of Medicinal Chemistry, 63, 869-881 (2013)
Suxiang Chen et al.
Scientific reports, 9(1), 6078-6078 (2019-04-17)
Antisense oligonucleotide (AO)-mediated splice modulation has been established as a therapeutic approach for tackling genetic diseases. Recently, Exondys51, a drug that aims to correct splicing defects in the dystrophin gene was approved by the US Food and Drug Administration (FDA)

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務